Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice.
Autosomal dominant GH deficiency type II (IGHDII) is often associated with mutations in the human GH gene (GH1) that give rise to products lacking exon-3 ((Deltaexon3)hGH). In the heterozygous state, these act as dominant negative mutations that prevent the release of human pituitary GH (hGH). To de...
Main Authors: | McGuinness, L, Magoulas, C, Sesay, A, Mathers, K, Carmignac, D, Manneville, J, Christian, H, Phillips, J, Robinson, I |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2003
|
Registos relacionados
-
A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice.
Por: Magoulas, C, et al.
Publicado em: (2000) -
Increasing hub disruption parallels dementia severity in autosomal
dominant Alzheimer’s disease
Publicado em: (2024-10-01) -
Autosomal Dominant Alternating Hemiplegia
Por: J Gordon Millichap
Publicado em: (1993-01-01) -
Autosomal Dominant Partial Epilepsies
Por: J Gordon Millichap
Publicado em: (2000-07-01) -
Autosomal Dominant Juvenile Amyotrophic LS
Por: J Gordon Millichap
Publicado em: (1999-09-01)